×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [4]
Faculty of Healt... [1]
THE STATE KEY LA... [1]
Authors
HU YUANJIA [3]
HE CHENGWEI [2]
CHEN XIN [1]
SU HUANXING [1]
HU HAO [1]
Document Type
Journal article [4]
Date Issued
2023 [1]
2022 [1]
2018 [2]
Language
英語English [4]
Source Publication
Journal of Advan... [2]
Current Pharmace... [1]
FRONTIERS IN IMM... [1]
Indexed By
SCIE [4]
SSCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-4 of 4
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape
Journal article
Kong,Xiangjun, Zuo,Huali, Huang,Hsien Da, Zhang,Qianru, Chen,Jiayu, He,Chengwei, Hu,Yuanjia. STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape[J]. Journal of Advanced Research, 2023, 44, 119-133.
Authors:
Kong,Xiangjun
;
Zuo,Huali
;
Huang,Hsien Da
;
Zhang,Qianru
;
Chen,Jiayu
; et al.
Favorite
|
TC[WOS]:
31
TC[Scopus]:
29
IF:
11.4
/
11.0
|
Submit date:2023/08/03
Agonists
Cancer Immunotherapy
Clinical Development
Patent Citation Network
Patent Landscape
Stimulator Of Interferon Genes (Sting)
STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape
Journal article
Xiangjun Kong, Huali Zuo, Hsien-Da Huang, Qianru Zhang, Jiayu Chen, Chengwei He, Yuanjia Hu. STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape[J]. Journal of Advanced Research, 2022, 44, 119-133.
Authors:
Xiangjun Kong
;
Huali Zuo
;
Hsien-Da Huang
;
Qianru Zhang
;
Jiayu Chen
; et al.
Favorite
|
TC[WOS]:
31
TC[Scopus]:
29
IF:
11.4
/
11.0
|
Submit date:2022/08/05
Stimulator Of Interferon Genes (Sting)
Patent Landscape
Patent Citation Network
Agonists
Cancer Immunotherapy
Clinical Development
Circadian rhythm and melatonin in the treatment of depression
Journal article
Satyanarayanan,Senthil Kumaran, Su,Huanxing, Lin,Yi Wen, Su,Kuan Pin. Circadian rhythm and melatonin in the treatment of depression[J]. Current Pharmaceutical Design, 2018, 24(22), 2549-2555.
Authors:
Satyanarayanan,Senthil Kumaran
;
Su,Huanxing
;
Lin,Yi Wen
;
Su,Kuan Pin
Favorite
|
TC[WOS]:
60
TC[Scopus]:
69
IF:
2.6
/
3.0
|
Submit date:2021/03/01
Antidepressants
Circadian Rhythm
Depression
Melatonin
Melatonin Receptor Agonists
Pharmacology
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents
Journal article
Zou, Huimin, Li, Ruixin, Hu, Hao, Hu, Yuanjia, Chen, Xin. Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents[J]. FRONTIERS IN IMMUNOLOGY, 2018, 9.
Authors:
Zou, Huimin
;
Li, Ruixin
;
Hu, Hao
;
Hu, Yuanjia
;
Chen, Xin
Favorite
|
TC[WOS]:
46
TC[Scopus]:
49
IF:
5.7
/
6.8
|
Submit date:2018/10/30
Tnf Receptor Type Ii
Regulatory t Cells
Tnf Receptor Type Ii Agonists
Tnf Receptor Type Ii Antagonists
Immunotherapy